Last update :
30/09/2022
Antihistamine (H2)   Famotidine  
Injection
Oral solution
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Nevofam - L Turkey
Quamatel Poland
Stability in solutions   Injection   Stability in solutions : Famotidine     
Container Solvent Concentration Temperature Storage Duration References
Polyvinyl chloride Water for Injection 2 mg/ml 4°C Protect from light
14 Day
690

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml -20°C Protect from light
28 Day
553

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 22°C With or without light
15 Day
215

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 25°C Not specified
15 Day
693

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 4°C Protect from light
14 Day
553

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,2 mg/ml 4°C Protect from light
63 Day
693

Polyvinyl chloride NaCl 0,9% or Glucose 5% 2 mg/ml 4°C Protect from light
14 Day
690

Polypropylen Syringe Water for Injection 2 mg/ml -20°C Protect from light
56 Day
77

Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,2 mg/ml 22°C With or without light
15 Day
215

Polypropylen Syringe Sodium chloride 0,9% 2 mg/ml -20°C Protect from light
56 Day
77

Polypropylen Syringe Glucose 5% 2 mg/ml -20°C Protect from light
21 Day
77


  Mentions Légales